Its also not ideal for people who only want compounded semaglutide or compounded tirzepatide
Venous thromboembolism is closely linked to metabolic disease, with obesity and diabetes promoting a prothrombotic state characterized by endothelial dysfunction, chronic low-grade inflammation, platelet activation, and impaired fibrinolysis ( Being a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist, tirzepatide produces substantial reductions in body weight ( Although incretin-based therapies have been extensively evaluated for their effects on atherosclerotic cardiovascular disease, their relationship with venous thromboembolism has been less clearly defined
These are associationsnot proven cause and effectand more robust research is needed to understand the biological mechanisms involved
doi: 10.1016/j.brainres.2010.11.013 49 LiRWuYZouSWangXLiYXuKet al
Its weight-loss drug policy would fall to Trump's pick for health secretary, Robert F Kennedy Jr, and Mehmet Oz, Trump's choice to lead Medicare and Medicaid services
Biology always wins